Restasis and Amerge drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Restasis (cyclosporine) and Amerge (naratriptan hydrochloride). Common drug interactions include haemorrhage among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Restasis and Amerge. It is created by eHealthMe based on reports of 47 people who take the same drugs from the FDA, and is updated regularly.

What is Restasis?

Restasis has active ingredients of cyclosporine. It is often used in dry eyes. eHealthMe is studying from 35,199 Restasis users. Check the latest studies of Restasis.

What is Amerge?

Amerge has active ingredients of naratriptan hydrochloride. It is often used in migraine. eHealthMe is studying from 1,470 Amerge users. Check the latest studies of Amerge.

On Jul, 12, 2026

47 people who take Restasis and Amerge together, and have interactions are studied.

What are the common drug interactions of Restasis and Amerge, by gender? *:

female:

Haemorrhage (bleeding)
Abdominal discomfort
Malaise (a feeling of general discomfort or uneasiness)
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Nausea (feeling of having an urge to vomit)
Pain
Viral infection
Hospitalisation
Headache (pain in head)
Nephrolithiasis (calculi in the kidneys)

male:

Abdominal pain
Clostridial infection (infectious conditions by clostridium bacteria)
Diarrhoea
Infusion site reaction
Lung infection
Nausea (feeling of having an urge to vomit)
Vomiting
Oedema peripheral (superficial swelling)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

What are the common drug interactions of Restasis and Amerge, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)

40-49:

Cystitis (inflammation of the wall of the bladder)
Hospitalisation
Memory impairment
Spinal fusion surgery
Urinary tract infection
Abdominal discomfort
Asthma
Bile output increased
Diplopia (double vision)
Dysgeusia (disorder of the sense of taste)

50-59:

Haemorrhage (bleeding)
Malaise (a feeling of general discomfort or uneasiness)
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Physical abuse
Viral infection
Weight decreased
Herpes zoster
Alopecia (absence of hair from areas of the body)
Drug ineffective
Fatigue (feeling of tiredness)

60+:

Nausea (feeling of having an urge to vomit)
Abdominal pain
Infusion related reaction
Oedema peripheral (superficial swelling)
Pain
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Pyrexia (fever)
Clostridial infection (infectious conditions by clostridium bacteria)
Diarrhoea
Infusion site reaction

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 31 people, 65.96%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 12 people, 25.53%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 6 people, 12.77%

* Approximation only. Some reports may have incomplete information.

Do you take Restasis and Amerge?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously